loader

ME Therapeutics Holdings

CSE:METX
ME Therapeutics is a pre-clinical biopharmaceutical company dedicated to the discovery and development of novel cancer immunotherapies.
Press Releases
ME Therapeutics is a pre-clinical biopharmaceutical company dedicated to the discovery and development of novel cancer immunotherapies. Using our combined expertise in tumour immunology, T cell biology and myeloid cell development, we are developing biological and small molecule drugs to target novel pathways involved in cancer-induced immune suppression. Our therapies have the potential to work on their own and in combination with other cancer immunotherapies across several cancer types.

Interactive Chart

×